Astaxanthin Production: Algalif's Sustainable Microalgae Cultivation in Iceland

Better materials have important indirect benefits: lower quantity combines with lower manufacturing energy and decarbonized supply to save more coal. Transporting less cement, steel, and coal frees rail capacity that can shift freight from road to rail. Construction and demolition waste is the world's largest non-agricultural waste stream totaling about half a ton per European per year. A Dutch technique for smart crushing with just one-tenth the normal force can selectively liberate about 40% unhydrated cement for valuable reuse in new concrete, potentially saving 2.5 gigatons of CO2 globally per year. A Turkish scientist discovered carboxylate chemistry that could make cement a net carbon sink of five-plus gigatons annually. The Belgian entrepreneur Good Cy illustrates industrial symbiosis with a Namibian brewery redesign: spent grain makes beer, bread, enzymes, chicken, mushrooms, pork, beef, algae, fish, fruits, and vegetables—all waste becomes food. This represents 11 products from one input.

Industrial symbiosis is a process where waste or by-products from one industry become raw materials for another, creating mutually beneficial collaborations that reduce environmental impact while improving business profitability; this circular economy approach offers both economic advantages such as enhanced competitiveness and new industry opportunities, and environmental benefits including reduced greenhouse gas emissions and natural resource depletion, though its implementation faces barriers like trust issues, regulatory uncertainties, technical challenges, and lack of awareness, which can be addressed through government incentives, research support, and appropriate legislation.

Traditional circular economy focuses on recycling within individual industries. The new paradigm involves industrial symbiosis where waste from one industry becomes raw material for another. Industries are strategically located in industrial parks to share materials, energy, and create circular systems. This approach works better than individual industry circularity because achieving zero waste generation is utopian. Professionals must prepare to advise not just single companies but entire industrial clusters working in symbiosis.

Industrial symbiosis and circular economy are related but distinct concepts. Industrial symbiosis focuses on geographically close production sites exchanging sufficiently large, stable flows of undervalued resources to establish symbiotic systems that minimize loss and waste while maximizing production. In contrast, circular economy encompasses geographically indefinite value networks that maintain, handle, and enable the continuous flow of resources from extraction through utilization to regeneration. Circular economy emphasizes adding value to resources and represents an economic system approach, whereas industrial symbiosis is a strategy specifically for value-producing systems within that broader circular economy framework.

Industrial symbiosis applies biological concepts to industrial systems, where companies share waste streams so residues become resources for others. The Kalundborg Industrial Park in Denmark exemplifies this with over 30 material exchanges including steam pipes connecting power stations to companies. Membership requires willingness to share streams, with associated members providing services and technologies. Success depends on multi-level collaboration spanning physical exchanges, legal frameworks, economic agreements, and supply security planning. Financial benefits include waste diversion from landfills, revenue from selling byproducts, and reduced transportation costs. Environmental protection increasingly strengthens the business case, making symbiosis economically viable without public subsidies.

Scaling up photobioreactors involves transitioning from small laboratory systems (using magnetic stirrers) to larger production systems (10-100 liters) by changing mixing methods to air stones, selecting appropriate materials like UV-filtered plastics for outdoor use, and utilizing carboy systems or modular reactor systems that provide replicates for consistent feedstock production.

Closed photobioreactors include horizontal tubular, vertical column, and flat panel systems. Comparison shows: tubular PBR offers maximum biomass yield and light exposure but highest O2/CO2 accumulation problems and medium maintenance; flat panel PBR provides good yield but highest manufacturing costs and lowest scale-up potential; column PBR balances performance with lower costs and easier scaling. Key differences from open systems include: space requirements (high vs low), water loss (high vs low), CO2 loss (high vs low), oxygen management (spontaneous outgassing vs controlled exchange), temperature control (variable vs precise), shear forces (low vs high), contamination risk (high vs low), biomass quality (variable vs reproducible), and production flexibility (limited vs high).

Bioreactor engineering requires collaboration between biologists and biomedical engineers. Submerged culture bioreactors include stirred tanks with impellers, airlift reactors using draft tubes, and bubble column reactors with spargers. Solid-state bioreactors handle degradation processes. Operation modes include batch, fed-batch, and continuous. Critical factors affecting production efficiency include gaseous atmosphere (O2, CO2), pH, mineral composition, sugar concentration, hormone levels, medium viscosity, and cell density. Standardization at laboratory level precedes industrial scale-up. Photobioreactors using sunlight power terpenoid production in moss and cyanobacteria.

This comprehensive section covers laboratory operations, analytical techniques, and photobioreactor design. The laboratory tour demonstrates laminar flow hoods for sterile work, analytical methods for carbohydrate and lipid analysis, and ash-free dry weight analysis using a 500°C muffle furnace. Standard Operating Procedures (SOPs) are emphasized as essential for reproducible results across laboratories. The cultivation section explains the scaling-up process from petri dish colonies through 1 ml cultures to 800 ml vertical tubular photobioreactors. Key concepts include nutrient deprivation triggering lipid production (indicated by color change from green to brown), contamination susceptibility from zooplankton and ciliates, and the critical balance between light intensity (200-500 microEinsteins) and photo-inhibition. Advanced analytical techniques include flow cytometry with imaging capturing cells at 10,000 per minute, fluorescence staining for lipid quantification, GCMS for lipid composition analysis, and LCMS for high-value products like astaxanthin. Large-scale processing includes freeze drying, evaporation systems, and cell disruption methods (Pulse Electric Field and high pressure homogenization). Photobioreactor design involves critical trade-offs: material degradation (acrylic-polycarbonate blends turn yellow and become brittle), path length stress (4 inches causes cracking), and orientation effects (north-south more reliable in hot climates). Pseudo column reactors using plastic bags reduce capital costs to one-third of acrylic systems but require more frequent replacement.

The photobioreactor was designed in a modular fashion with eight modules, each containing 16 acrylic tubes (110mm diameter, 3.5m tall) with approximately 400 liters per module. The serpentine reactor was split into three sections that could be isolated and inoculated sequentially, facilitating cell line scale-up without requiring large initial inocula (typically 10-20% of total reactor volume). This modular approach allowed construction at Swansea University and assembly at the Plymouth site.

Metabolic engineering transfers biosynthetic pathways from natural sources into tractable hosts using iterative design-build-test-learn cycles. Green algae present unique genetic challenges requiring introns for proper gene expression, a discovery that enabled practical genetic manipulation after decades of failed attempts. Wild-type algae require domestication through mutagenesis to enable tractable handling. Combined with robotics for high-throughput screening, these solutions transformed difficult-to-manipulate organisms into powerful platforms for producing complex natural products. The development of automated systems and optimized genetic tools represents the foundation of modern algal biotechnology.

This section explores the cutting-edge biotechnological capabilities enabling algae biofuel advancement. It begins by emphasizing the enormous genetic diversity of algae (~3 million species) representing more variation than all higher animals and plants combined, enabling trait mining for improving terrestrial crops. The presentation then details genetic transformation methods: particle bombardment achieving transgenic lines within 10 days and homoplasmic lines in six weeks; chloroplast transformation using homologous recombination with flanking regions and codon optimization; and nuclear transformation offering better regulatory control. The section demonstrates practical applications: high-level expression of bovine serum amyloid A3 protein improving animal gut health; production of seven human therapeutic proteins including VEGF, HMGB1, and fibronectin; and monoclonal antibodies with binding activity comparable to mammalian-expressed versions. Metabolic engineering achievements are highlighted: production of limonene (C10 monoterpene) and C30 hydrocarbons, with catalytic cracking producing gasoline with octane ratings matching commercial fuels. Current commercial markets ($3.5B for spirulina, $1.5B for omega-3 fatty acids) provide economic foundations for scaling infrastructure.

Algae can be domesticated and genetically engineered like traditional crops, with the genomic revolution enabling rapid development. Algae are eukaryotic organisms that can be transformed by introducing genes into nuclear or chloroplast genomes. Chloroplasts, derived from photosynthetic bacteria, have simpler regulatory systems but retain protein folding machinery. Scientists have created rainbow-colored algae using fluorescent proteins for cellular labeling and high-throughput screening. Metabolic engineering enables production of biofuels (limonene from isoprenoid pathways) and immunotoxins (antibody-toxin conjugates for cancer treatment). Algae uniquely produce immunotoxins because chloroplasts can fold complex proteins without being susceptible to eukaryotic toxins. These immunotoxins, currently priced at $160,000, could be produced more affordably in algae.

The pipeline from natural discovery to industrial application involves systematic bioprospecting across diverse geographic locations, isolating pure cultures, and characterizing biochemical properties including protein, carbohydrate, and lipid content. Controlled environmental testing across seasons predicts strain performance in different conditions. Metabolic engineering adapts plant-derived pathways for algal hosts to produce scalable quantities of valuable chemicals including di-Turpin platform chemicals, modified pigments, altered fatty acids, and recombinant proteins. Chlamydomonas reinhardtii serves as a model organism due to its ease of cultivation but presents engineering challenges including transgene size limitations (over 1KB fails to express), random genomic integration, and the requirement for intron spacing every 450-500 base pairs for proper foreign gene expression. These findings enabled expression of large genes by mimicking natural intron patterns, transforming algae engineering from labor-intensive trial-and-error into a systematic, scalable process.

Genetic engineering can be applied to algae for various applications beyond food production. Algae can be engineered to produce biofuels like ethanol derived from corn or genetically modified algae. Additionally, diatoms—special forms of algae with cell walls made of silica—are being explored for nano-engineering applications. These living organisms with glass-like cell walls can be arranged onto surfaces to create biosensors for detecting explosives or delivering drugs inside the body, demonstrating how genetic manipulation of simple organisms enables advanced technological applications.